2 results
Approved WMORecruiting
The primary objective of the study is to demonstrate that lenvatinib in combination with everolimus (Arm A) or pembrolizumab (Arm B) is superior compared to sunitinib alone (Arm C) in improving progressionfree survival (PFS) (by independent imaging…
Approved WMOCompleted
To reduce stress-related problems and increases reintegration of work, the company Letec developed a technique that utilizes the light therapy / magnetic therapy treatment platform Xentix besides coaching. In order to demonstrate the effectiveness…